ADAR1 Capital Management, LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$1.1B
Holdings
203
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (203 positions)
| Stock | Value |
|---|---|
ABVXABIVAX SA | $114.7M |
KROSKEROS THERAPEUTICS INC | $85.3M |
SPYSPDR S&P 500 ETF TR | $66.7M |
PTGXPROTAGONIST THERAPEUTICS INC | $65.7M |
ROIVROIVANT SCIENCES LTD | $50.6M |
BOXXEA SERIES TRUST | $38.4M |
IMVTIMMUNOVANT INC | $36.1M |
ETNBGBP89BIO INC | $31.1M |
ZLABZAI LAB LTD | $29.4M |
CYTKCYTOKINETICS INC | $28.5M |
SEPNSEPTERNA INC | $22.1M |
QUREUNIQURE NV | $19.5M |
PRTAPROTHENA CORP PLC | $14.3M |
BBIOBRIDGEBIO PHARMA INC | $14.2M |
I9DNARBUTUS BIOPHARMA CORP | $13.2M |
RAPTRAPT THERAPEUTICS INC | $13.1M |
CTMXCYTOMX THERAPEUTICS INC | $12.9M |
BILSPDR SERIES TRUST | $12.4M |
AMLXAMYLYX PHARMACEUTICALS INC | $11.8M |
BIOABIOAGE LABS INC | $11.1M |
MNPRMONOPAR THERAPEUTICS INC | $10.6M |
YCYAA MISSION ACQUISITION CORP | $10.3M |
CRNXCRINETICS PHARMACEUTICALS IN | $10.3M |
LXEOLEXEO THERAPEUTICS INC | $10.2M |
CGONCG ONCOLOGY INC | $10.0M |
TSHATAYSHA GENE THERAPIES INC | $9.3M |
REGNREGENERON PHARMACEUTICALS | $8.8M |
ISIIONIS PHARMACEUTICALS INC | $8.8M |
JANXJANUX THERAPEUTICS INC | $8.6M |
IKTINHIBIKASE THERAPEUTICS INC | $8.5M |
IVVDINVIVYD INC | $8.1M |
MTSRMETSERA INC | $8.0M |
EQEQUILLIUM INC | $8.0M |
—PERCEPTIVE CAP SOLUTIONS COR | $7.9M |
PCVXVAXCYTE INC | $7.7M |
RZLTREZOLUTE INC | $7.7M |
XENEXENON PHARMACEUTICALS INC | $7.6M |
ASNDASCENDIS PHARMA A/S | $7.2M |
YB4PSAVARA INC | $7.1M |
SRPTSAREPTA THERAPEUTICS INC | $6.7M |
RVMDREVOLUTION MEDICINES INC | $6.5M |
BBOTBRIDGEBIO ONCOLOGY THERAPEUT | $5.8M |
VRNAVERONA PHARMA PLC | $5.5M |
OACCOAKTREE ACQUISITION CORP III | $5.5M |
TEVATEVA PHARMACEUTICAL INDS LTD | $5.4M |
RYTMRHYTHM PHARMACEUTICALS INC | $5.0M |
ATAIATAI LIFE SCIENCES NV | $4.8M |
UTHUNITED THERAPEUTICS CORP DEL | $4.7M |
VKTXVIKING THERAPEUTICS INC | $4.6M |
BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | $4.4M |
REPLREPLIMUNE GROUP INC | $4.3M |
NKTRNEKTAR THERAPEUTICS | $4.1M |
XBISPDR SERIES TRUST | $4.0M |
FULCFULCRUM THERAPEUTICS INC | $3.8M |
ESTAESTABLISHMENT LABS HLDGS INC | $3.7M |
SNYSANOFI SA | $3.5M |
KRYSKRYSTAL BIOTECH INC | $3.3M |
NAMSNEWAMSTERDAM PHARMA COMPANY | $3.3M |
MRUSMERUS N V | $3.1M |
MLYSMINERALYS THERAPEUTICS INC | $3.0M |
KNSAKINIKSA PHARMACEUTICALS INTL | $2.9M |
TCE2CELLDEX THERAPEUTICS INC NEW | $2.8M |
ZURAZURA BIO LTD | $2.8M |
BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | $2.8M |
VRTXVERTEX PHARMACEUTICALS INC | $2.7M |
ACLXARCELLX INC | $2.6M |
BIIBBIOGEN INC | $2.5M |
DCTHDELCATH SYS INC | $2.4M |
RNAAVIDITY BIOSCIENCES INC | $2.3M |
MDGLMADRIGAL PHARMACEUTICALS INC | $2.2M |
ASPCRA SPAC III ACQUISITION CORP | $2.2M |
3M4MASIMO CORP | $2.2M |
VRDNVIRIDIAN THERAPEUTICS INC | $2.2M |
SMMTSUMMIT THERAPEUTICS INC | $2.1M |
CDTXCIDARA THERAPEUTICS INC | $2.1M |
RGNXREGENXBIO INC | $2.0M |
KRROKORRO BIO INC | $1.9M |
RCKTROCKET PHARMACEUTICALS INC | $1.9M |
OABIOMNIAB INC | $1.7M |
ARWRARROWHEAD PHARMACEUTICALS IN | $1.7M |
SLNOSOLENO THERAPEUTICS INC | $1.7M |
DVAXDYNAVAX TECHNOLOGIES CORP | $1.7M |
ALKSALKERMES PLC | $1.7M |
GLUEMONTE ROSA THERAPEUTICS INC | $1.6M |
MRKMERCK & CO INC | $1.6M |
CCIICOHEN CIRCLE ACQUISIT CORP I | $1.5M |
ABOSACUMEN PHARMACEUTICALS INC | $1.5M |
XNCRXENCOR INC | $1.5M |
URGNUROGEN PHARMA LTD | $1.5M |
AGIOAGIOS PHARMACEUTICALS INC | $1.5M |
WWWW INTL INC | $1.4M |
CATBUSDASTRIA THERAPEUTICS INC | $1.4M |
CNTACENTESSA PHARMACEUTICALS PLC | $1.3M |
QNCXQUINCE THERAPEUTICS INC | $1.3M |
MLTXMOONLAKE IMMUNOTHERAPEUTICS | $1.2M |
PFEPFIZER INC | $1.1M |
GRCEGRACE THERAPEUTICS INC | $1.0M |
NUVLNUVALENT INC | $1.0M |
BSAABEST SPAC I ACQUISITION CORP | $1.0M |
EAELECTRONIC ARTS INC | $996K |
Page 1 of 3Next